• Monday, August 26, 2024 @ 12:00 am

AllesHealth, a renowned provider of comprehensive healthcare solutions for clinics and patients, announces a strategic partnership with Biorce, a leading innovator in AI for drug development. This collaboration is set to transform the landscape of clinical trials by integrating Biorce’s cutting-edge AI technology with AllesHealth’s advanced Clinic & Patient Management solutions

This collaboration will harness Biorce’s cutting-edge technology alongside AllesHealth’s robust, structured data to significantly enhance the precision of matching patients with suitable clinical trials. By integrating Biorce’s innovative solutions into AllesHealth’s comprehensive healthcare ecosystem, they aim to bridge critical gaps in clinical care. This partnership will not only improve patient matching but also boost patient awareness, ensuring that more individuals receive the right opportunities for participation in clinical trials. Ultimately, the combined efforts will lead to a superior patient experience and more effective healthcare outcomes.

"At AllesHealth, our commitment to delivering the highest quality care to our patients is unwavering. Partnering with Biorce marks a significant milestone in our mission to revolutionize healthcare delivery and establish new standards for patient care," said Sundeep Gaba, Founder of AllesHealth. "This collaboration is a key component of our ongoing efforts to advance integrated digital healthcare for both HCPs and patients through our Partner For Good initiative."

Pedro Coelho, CEO of Biorce, states, "We are thrilled to partner with AllesHealth, a company that shares our passion for advancing healthcare through innovation. This collaboration will create a powerful synergy that will benefit everyone in the drug development ecosystem."

The partnership between AllesHealth and Biorce is expected to yield a range of benefits, including:

  • Enhanced Patient Awareness:
    By integrating Biorce's advanced AI models with AllesHealth's structured real-world data, patients are provided with a deeper understanding of their treatment options and this will empower patients to make more informed decisions about their healthcare journey.
  • Increased Efficiency for CROs, Sponsors, and Clinics:
    The partnership will streamline the clinical trial process, leading to increased efficiency across the board. CROs, Sponsors, and Clinics will benefit from reduced operational costs and shorter patient enrollment times, while physicians will experience a more efficient pre-screening process, allowing them to focus more on patient care.
  • Better Access to Trials:
    By combining AllesHealth’s comprehensive real-world data with Biorce's cutting-edge AI models, trial mapping becomes more personalized and accessible. 

AllesHealth and Biorce are confident that this partnership will have a profound impact on the future of healthcare, setting new benchmarks for innovation and patient care.

You may also be interested in